Medi-Caps Ltd.
•Add ratio to table
ABOUT
KEY POINTS
Revenue Breakup Mar 2026 • Pharma Division: 81.5% • Real Estate Division: 18.5%
AI Sector View
AI GENERATEDChemicals
The available domestic chemical proxies are mixed to weak. Fertilizers output was -8.0% YoY (2026-07) and sale quantity of fertilisers was 0.0% YoY (2026-05), although that high-frequency barometer is stale. FPI positioning is less negative than before, with net 3-month outflow only INR -11 crore versus INR -1229 crore in the prior 3 months to 2026-08-31, but the weak sector driver argues for a neutral stance.
PROS
- Company is almost debt free
- Company generates healthy free cash flow
CONS
- Company is loss-making at the operating / net level
- Operating cash flow has been negative in recent years
- Interest coverage is weak at -137.1x - earnings barely cover interest
- Receivables are growing faster than sales - a possible quality concern
- Company has a low return on capital employed of -1.4%
- Company has a low return on equity of -1.7% over last 3 years
* The pros and cons are machine generated based on quantitative rules.
Peer comparison
| Name | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| SOLARINDS | 21410.70 | 97.29 | 193745.54 | 0.05 | 666.37 | 88.98 | 3668.20 | 70.26 | 38.16 | 27.91 |
| PIDILITIND | 1632.00 | 62.71 | 166117.97 | 1.32 | 8835.10 | 1202.86 | 45515.50 | 1112.74 | 32.38 | 26.28 |
| SRF | 2605.00 | 35.72 | 77218.67 | 0.35 | 758.87 | 75.53 | 5033.26 | 34.63 | 14.21 | 24.57 |
| FLUOROCHEM | 4691.60 | 83.80 | 51537.23 | 0.06 | 219.00 | 19.02 | 1588.00 | 23.97 | 9.58 | 26.83 |
| NAVINFLUOR | 8697.20 | 56.51 | 44623.69 | 0.17 | 243.31 | 107.67 | 1045.08 | 44.07 | 21.39 | 34.17 |
| GODREJIND | 1155.90 | 33.12 | 38936.61 | 0.00 | 523.36 | -27.85 | 5448.09 | 22.16 | 10.64 | 12.82 |
| DEEPAKNTR | 1727.25 | 30.08 | 23558.49 | 0.43 | 345.01 | 207.36 | 2577.60 | 36.39 | 11.58 | 20.96 |
| AETHER | 1656.35 | 93.47 | 21984.38 | 0.00 | 62.75 | 33.45 | 326.56 | 27.49 | 11.65 | 31.47 |
| ATUL | 6465.50 | 23.93 | 19035.57 | 0.46 | 253.93 | 91.85 | 1847.95 | 25.03 | 15.05 | 21.41 |
| AARTIIND | 501.75 | 34.27 | 18199.81 | 0.20 | 155.00 | 260.47 | 2387.00 | 42.42 | 6.95 | 16.00 |
| DEEPAKFERT | 1356.30 | 17.46 | 17179.29 | 0.74 | 490.04 | 100.95 | 3256.26 | 22.47 | 12.12 | 25.96 |
| MEDICAPQ | 24.53 | 0.00 | 30.59 | 0.00 | -2.23 | 36.05 | 2.79 | 3.99 | -2.58 | -65.73 |
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 6 | 6 | 7 | 7 | 6 | 8 | 4 | 7 | 3 | 2 | 4 | 3 | 3 | |
| 7 | 6 | 6 | 8 | 6 | 8 | 6 | 7 | 6 | 5 | 5 | 6 | 5 | |
| Operating Profit | -1 | 0 | 1 | -1 | -0 | 0 | -2 | -0 | -3 | -3 | -1 | -2 | -2 |
| OPM % | -13.94% | 7.51% | 7.95% | -12.80% | -5.20% | 5.31% | -44.64% | -3.60% | -126.49% | -145.27% | -24.94% | -61.11% | -81.95% |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 0 | 2 | 1 | 6 | 0 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before Tax | -1 | 0 | 0 | -1 | -1 | 0 | -2 | 1 | -3 | -2 | -1 | 3 | -2 |
| Tax % | -0.00% | 0.00% | 150.00% | -83.05% | -0.00% | 0.00% | -0.00% | -18.62% | -0.00% | -0.00% | -4.05% | -0.33% | -0.00% |
| Net Profit | 0 | 0 | 0 | 0 | -1 | 0 | -2 | 2 | -3 | -2 | -1 | 3 | -2 |
| -0.89 | 0.09 | -0.13 | -0.86 | -0.45 | 0.25 | -1.64 | 1.38 | -2.80 | -1.46 | -0.61 | 2.44 | -1.79 |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 44 | 50 | 52 | 43 | 59 | 70 | 49 | 27 | 25 | 12 | 13 | |
| 42 | 48 | 47 | 50 | 46 | 60 | 44 | 27 | 27 | 22 | 21 | |
| Operating Profit | 2 | 2 | 5 | -7 | 12 | 10 | 5 | 0 | -2 | -9 | -8 |
| OPM % | 3.63% | 4.35% | 9.12% | -15.72% | 20.91% | 14.40% | 10.51% | 0.01% | -7.08% | -75.52% | -66.87% |
| 2 | 1 | 3 | 3 | 1 | 2 | 2 | 0 | 3 | 8 | 8 | |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Profit before Tax | 2 | 1 | 6 | -6 | 11 | 10 | 5 | -1 | -1 | -3 | -2 |
| Tax % | 20.53% | 14.85% | 2.12% | -0.14% | -0.05% | 0.14% | 62.07% | -79.84% | 32.11% | -0.47% | -1.13% |
| Net Profit | 1 | 1 | 5 | -6 | 11 | 10 | 2 | -2 | -1 | -3 | -2 |
| EPS | 0.00 | 0.00 | 0.00 | -3.73 | 8.93 | 8.08 | 1.41 | -1.80 | -0.46 | -2.44 | — |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | — |
COMPOUNDED SALES GROWTH
- 10 Years:
- -12%
- 5 Years:
- -27%
- 3 Years:
- -37%
COMPOUNDED PROFIT GROWTH
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
STOCK PRICE CAGR
- 10 Years:
- —
- 5 Years:
- —
- 3 Years:
- —
- 1 Year:
- —
RETURN ON EQUITY
- 10 Years:
- 2%
- 5 Years:
- 1%
- 3 Years:
- -2%
- Last Year:
- -3%
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 | 12 |
| 77 | 78 | 83 | 78 | 92 | 104 | 106 | 109 | 109 | 99 | |
| Trade Payables | 4 | 6 | 6 | 2 | 6 | 12 | 3 | 2 | 2 | 0 |
| 4 | 4 | 4 | 2 | 4 | 2 | 5 | 4 | 3 | 3 | |
| Total Liabilities | 97 | 101 | 107 | 95 | 115 | 130 | 126 | 127 | 125 | 115 |
| 61 | 60 | 59 | 57 | 58 | 59 | 59 | 58 | 56 | 55 | |
| Capital Work in Progress | 0 | 0 | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| 9 | 12 | 17 | 22 | 28 | 31 | 32 | 39 | 44 | 36 | |
| 13 | 10 | 11 | 5 | 7 | 12 | 7 | 6 | 3 | 3 | |
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 11 | 9 | 7 | |
| Cash & Bank | 2 | 2 | 2 | 1 | 7 | 10 | 1 | 0 | 0 | 1 |
| 12 | 16 | 17 | 8 | 14 | 19 | 27 | 13 | 13 | 14 | |
| Total Assets | 97 | 101 | 107 | 95 | 115 | 130 | 126 | 127 | 125 | 115 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 4 | 4 | 6 | 5 | 15 | 7 | -3 | 7 | 5 | -7 | |
| Cash from Investing | 3 | -4 | -6 | -6 | -10 | -4 | -3 | -8 | -5 | 7 |
| Cash from Financing | -6 | 0 | -0 | -0 | -0 | 0 | 0 | 0 | 0 | 0 |
| 1 | 0 | 0 | -1 | 6 | 3 | -9 | -1 | 0 | 0 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
| Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|
| PER SHARE | ||||||||||
| EPS (₹) | 1.10 | 0.92 | 4.32 | -4.69 | 8.92 | 8.08 | 1.41 | -1.80 | -0.46 | -2.44 |
| Book Value (₹) | 71.44 | 72.35 | 76.67 | 72.94 | 83.97 | 93.23 | 95.09 | 97.02 | 97.25 | 89.50 |
| Dividend per Share (₹) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash EPS (₹) | 2.55 | 2.36 | 5.78 | -3.23 | 10.24 | 9.51 | 2.89 | -0.44 | 0.92 | -0.99 |
| PROFITABILITY | ||||||||||
| Operating Margin % | 7.79% | 5.98% | 13.45% | -8.65% | 21.91% | 17.14% | 13.76% | 0.01% | -7.08% | -75.52% |
| Net Margin % | 2.94% | 2.12% | 9.72% | -12.99% | 19.15% | 14.37% | 3.78% | -8.19% | -2.24% | -24.40% |
| ROE % | 1.60% | 1.28% | 5.80% | -6.27% | 11.49% | 9.09% | 1.59% | -1.87% | -0.47% | -2.61% |
| ROCE % | 2.12% | 1.61% | 6.06% | -6.13% | 11.59% | 9.20% | 4.30% | -1.01% | -0.66% | -2.58% |
| 1.44% | 1.16% | 5.19% | -5.80% | 10.71% | 8.19% | 1.46% | -1.77% | -0.45% | -2.52% | |
| EFFICIENCY | ||||||||||
| Debtor Days | 73 | 74 | 85 | 70 | 34 | 43 | 69 | 129 | 140 | 230 |
| Inventory Days | 110 | 79 | 69 | 66 | 38 | 48 | 70 | 85 | 64 | 90 |
| Payable Days | 89 | 77 | 95 | 63 | 57 | 118 | 125 | 97 | 63 | 72 |
| 94 | 76 | 60 | 74 | 15 | -26 | 14 | 117 | 141 | 249 | |
| FINANCIAL HEALTH | ||||||||||
| Debt to Equity (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| Interest Coverage (x) | 19.00x | 14.43x | 42.94x | -48.87x | 110.44x | 93.95x | 39.47x | -33.04x | -16.63x | -137.05x |
| 4.89x | 4.14x | 4.59x | 9.82x | 5.68x | 5.05x | 9.43x | 11.41x | 17.25x | 17.34x | |
| GROWTH | ||||||||||
| Revenue Growth % | 2.48% | 12.80% | 4.24% | -16.86% | 36.39% | 18.99% | -29.34% | -44.61% | -6.83% | -51.14% |
| Operating Profit Growth % | 10.26% | -10.63% | 130.07% | -152.26% | 430.16% | -6.88% | -43.30% | -92.98% | 93.84% | -229.03% |
| Net Profit Growth % | 58.36% | -16.11% | 369.44% | -208.63% | 292.16% | -10.69% | -81.42% | -220.06% | 74.52% | -431.96% |
| 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -227.64% | 74.52% | -431.95% | |
| VALUATION | ||||||||||
| P/E (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x |
| P/B (x) | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.46x | 0.43x | 0.26x |
| Dividend Yield % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 115.19x | 55.53x | -23.82x |
Documents
Corporate disclosures, annual reports, credit ratings, and concall transcripts
No announcements filed.
News
Recent coverage and analyst commentary for MEDICAPQ
Loading news…
AI Stock Analyst
Medi-Caps Ltd.
Sign in to Chat with AI
Log in with your 5nance account to ask institutional questions about performance, financials, and outlook.
✨ Sign In to ChatFree 5nance Account

